FluoroType® NG is based on an innovative fluorescence-based technology and allows for the detection of Neisseria gonorrhoeae directly from urethral or cervical swabs and urine.
The test system FluoroType® NG allows for the rapid and reliable detection of Neisseria gonorrhoeae directly from patient specimens such as urethral or cervical swabs and urine. Additionally, the DNA extracted for FluoroType® NG can also be used with FluoroType® CT for the identification of Chlamydia trachomatis. Both tests can be combined easily as they can be processed simultaneously with the FluoroCycler® 12.
For the innovative FluoroType® NG, bacterial DNA is manually extracted from patient specimens using FluoroLyse. The subsequent amplification and detection run fully automated in the FluoroCycler® 12 instrument. Results are interpreted by the specific and user-friendly FluoroSoftware® and are available after only three hours.
Please contact your local representative for availability in your country.
Not for sale in the USA.
Legal Manufacturer is Hain Lifescience GmbH – A Bruker Company